Malignant tumors are characterized by uncontrolled division of cells able to invade adjacent tissues and metastasize. Nowadays there exist numerous theories of origination of malignant tumors, one of them is viral theory (for example virus of Hepatitis B increases risk of hepatic tumors and human papilloma virus plays an important role in development of cancer of cervix uteri). Until recently oncological diagnosis was equated to a death sentence. But now it isn’t like that especially with timely diagnosis and adequate treatment. Nowadays the most commonly used methods for treatment of cancer are: drug therapy (chemotherapy, hormonotherapy and immunotherapy), radiotherapy, cryotherapy and surgical treatment.
Results of study of biological activity of EnergoIod in tumor models showed not only absence of stimulating effect on tumor growth but also ability to bind carcinogenic agents and eliminate them from organism. Direct programmed destruction of cells was observed (apoptosis).
There is a potential possibility of using EnergoIod along with traditional antitumoral therapy in treatment of oncological diseases:
- antiviral and antibacterial effects (viral theory of cancer is one of the leading);
- antimutagenic effect - prevention of changes in genetic apparatus of cells;
- anticarcinogenic effect - ability to bind carcinogenic agents and eliminate them from organism;
- antimetastatic effect - prevention of spreading of cancerous cells in other tissues and organs;
- antiestrogenic effect - prevention of development of hormone-dependent tumors in female genital system;
- normalization of immunity;
- this preparation improves general condition of patients especially in early postoperative period;
- improves tolerance for cytostatic treatment, enhances antitumoral effect of chemotherapy and mitigates side effects of chemo- and radiotherapy;
- stimulates hemopoiesis and leucopoiesis effectively;
- enhances ability to adapt to influence of environmental factors and infections;
- the preparation has secondary analgesic effect;
- the prepration has regenerative effect. Timely use of EnergoIod reduces significantly risk of cicatrical changes, stimulates regenerative processes in smoldering wounds, ulcers and bedsores;
- EnergoIod in combination with traditional antitumoral therapy improves significantly quality of life, increases survival index and tolerance for treatment.
EnergoIod preparation can be used successfully in prevention and combination therapy of oncological diseases.
Use of EnergoIod in this disease
Use of EnergoIod in this disease
Weight, kg
For disease
Lung disease
Average disease
Severe disease
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
40
2
4
4
8
6
12
50-60
3
6
6
12
9
18
70-80
4
8
8
16
12
24
90-100
5
10
10
20
15
30
110-120
6
12
12
24
17
34
Use of a concentrate
Shake before use. It requires dilution with cold or cool drinking water (in an amount of 100-200 ml).
The daily dose calculated for 1 kg body weight, depending on the severity and course of the disease is 0.1-0.3 ml / kg body weight / day, divided into 2 doses.
The drug is taken on an empty stomach in the morning and in the evening before going to bed for 30 days.
If necessary, a second course in 15 days.
The number of courses per year depending on the severity of the pathological process.
Carrying out an accelerated rate with the maximum dose for 15 days.